Please use this identifier to cite or link to this item:
Title: Genome editing in human pluripotent stem cells: a systematic approach unrevealing pancreas development and disease
Author: Garreta, Elena
Marco, Andrés
Izpisúa Belmonte, Juan Carlos
Montserrat, Núria
Keywords: Malalties hereditàries
Genètica humana
Malalties del pàncrees
Genetic diseases
Genètica humana
Pancréas diseases
Issue Date: 14-Nov-2016
Publisher: AME
Abstract: Although mouse models have represented a major tool for understanding and predicting molecular mechanisms responsible for several human genetic diseases, still species-specific differences between mouse and humans in their biochemical and physiological characteristics represent a major hurdle when translating promising findings into the human setting (1). For instance, in several types of maturity onset diabetes of the young (MODY; autosomal dominant), mice with heterozygous mutations do not develop diabetes (2). In this regard, the derivation of human embryonic stem cells (hESCs) in 1998 represented an unprecedented opportunity for human disease modelling, and a promising source for cell replacement therapies (3). Later on, the possibility to generate patient-derived induced pluripotent stem cells (iPSCs) has opened new venues for the potential translation of stem-cell related studies into the clinic (4).
Note: Reproducció del document publicat a:
It is part of: Stem Cell Investigation 2016, vol. 4, num. 11, p. 1-4
Related resource:
ISMN: 2313-0792
Appears in Collections:Articles publicats en revistes (Institut de Bioenginyeria de Catalunya (IBEC))
Publicacions de projectes de recerca finançats per la UE

Files in This Item:
File Description SizeFormat 
L16_2016_Stem Cell Investigation_4_1.pdf148.23 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.